Ecolab
ECL NYSE Specialty Chemicals Financials FY2016βFY2025
Ecolab's revenue rose 2.2% to $16.1 billion in fiscal 2025. Its operating margin was 17.0%, down from 17.8% a year earlier. Free cash flow was $1.9 billion, up 4.7%. It paid out $1.5 billion in dividends and buybacks, 81% of free cash flow. The diluted share count fell 0.5%.
About these figures. Total debt is the balance sheet's long-term debt plus its current debt line.
What Ecolab does
No business description yet.
- Legal name
- ECOLAB INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001104659-26-018357
0000031462
Revenue and margins
Ecolab had $16.1B of revenue in fiscal 2025, up 2.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 6.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.9B in fiscal 2025, 11.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ecolab returned $1.5B to shareholders in fiscal 2025, 81% of free cash flow. The diluted share count fell 0.5%.
Value Ecolab yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$7.6B and divides by 285.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 38.7x Β· peers 31.1x Β· sector 20.1x.
Balance sheet
Cash, debt and the ratios that show how comfortably Ecolab can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $360M | $599M | $920M | $1.3B | $646M |
| Debt incl. finance leases | $8.8B | $8.6B | $8.2B | $7.6B | $8.2B |
| Net debt / EBITDA | 3.4x | 3.2x | 2.5x | 1.7x | 2.0x |
| Debt / equity | 1.2x | 1.2x | 1.0x | 0.9x | 0.8x |
| Interest coverage | 6.9x | 6.2x | 5.7x | 8.2x | 8.9x |
| Current ratio | 1.3x | 1.3x | 1.3x | 1.3x | 1.1x |
| Quick ratio | 0.9x | 0.9x | 1.0x | 1.0x | 0.8x |
| Total assets | $21.2B | $21.5B | $21.8B | $22.4B | $24.7B |
| Total liabilities | $14.0B | $14.2B | $13.8B | $13.6B | $14.9B |
| Shareholders' equity | $7.2B | $7.2B | $8.0B | $8.8B | $9.8B |
| Net debt (β = net cash) | $8.4B | $8.0B | $7.3B | $6.3B | $7.6B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$3.7M
4 insiders
Sold, 12 months
$11.6M
6 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Eric Mark GreenDirector | Bought | 3,690 | $276.64 | $1.0M | Form 4 |
| Aug 18, 2026 | Christophe BeckChairman, President & CEO, Director | Sold | 17,862 | $280.14 | $5.0M | Form 4 |
| Aug 11, 2026 | Gregory B CookCo-COO - Global Businesses | Sold | 4,567 | $285.13 | $1.3M | Form 4 |
| Jul 30, 2026 | Scott D KirklandChief Financial Officer | Sold | 3,357 | $276.96 | $0.9M | Form 4 |
| Jun 11, 2026 | Benjamin M. ClarkEVP - Global Supply Chain | Bought | 1,000 | $263.83 | $0.3M | Form 4 |
| Jun 10, 2026 | Michel D DoukerisDirector | Bought | 7,750 | $258.00 | $2.0M | Form 4 |
| Jun 9, 2026 | Darrell R BrownCo-COO - Global Markets | Sold | 10,000 | $260.89 | $2.6M | Form 4 |
| May 27, 2026 | Suzanne M VautrinotDirector | Sold | 1,004 | $264.98 | $0.3M | Form 4 |
| May 13, 2026 | David MacLennanDirector | Bought | 1,000 | $250.65 | $0.3M | Form 4 |
| May 4, 2026 | David MacLennanDirector | Bought | 800 | $256.91 | $0.2M | Form 4 |
| Feb 26, 2026 | Gregory B CookEVP & Pres - Inst Group | Sold | 3,519 | $304.25 | $1.1M | Form 4 |
| Feb 25, 2026 | Tracy B McKibbenDirector | Sold | 1,265 | $308.66 | $0.4M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 7 / 9 | 5 / 9 |
| Accruals ratio | β4.8% | β3.2% | β3.7% |
| Altman Z'' | 3.12 | 3.56 | 3.24 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Ecolab ECL | $81.4B | 2.2% | 17.0% | 11.8% | 13.8% | 38.7x | 5 | |
| PPG Industries PPG | $24.8B | 0.2% | β | 7.3% | 14.4% | 15.8x | 7 | Compare β |
| Westlake WLK | $8.3B | β8.0% | β14.1% | β4.7% | β10.0% | β | 3 | Compare β |
| Sherwin-Williams SHW | $82.9B | 2.1% | β | 11.3% | 19.9% | 31.1x | 6 | Compare β |
| International Flavors & Fragrances IFF | $24.2B | β5.2% | β3.5% | 2.4% | β1.4% | 82.6x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $13.2B | $13.8B | $12.2B | $12.6B | $11.8B | $12.7B | $14.2B | $15.3B | $15.7B | $16.1B |
| Gross profit | $5.6B | $5.8B | $5.3B | $5.5B | $4.9B | $5.1B | $5.4B | $6.2B | $6.8B | $7.2B |
| Research and development | $189M | $201M | $193M | $190M | $185M | $186M | $190M | $192M | $207M | $202M |
| Operating income | $1.9B | $2.0B | $1.7B | $1.8B | $1.4B | $1.6B | $1.6B | $2.0B | $2.8B | $2.7B |
| Interest expense | $285M | $275M | $236M | $214M | $305M | $231M | $252M | $349M | $340M | $306M |
| Pretax income | $1.6B | $1.8B | $1.6B | $1.7B | $1.2B | $1.4B | $1.3B | $1.8B | $2.6B | $2.5B |
| Income tax | $403M | $244M | $321M | $289M | $177M | $270M | $235M | $363M | $439M | $455M |
| Net income | $1.2B | $1.5B | $1.4B | $1.6B | β$1.2B | $1.1B | $1.1B | $1.4B | $2.1B | $2.1B |
| Diluted EPS | $4.14 | $5.12 | $4.88 | $5.33 | β$4.15 | $3.91 | $3.81 | $4.79 | $7.37 | $7.28 |
| Diluted shares | 0.30B | 0.29B | 0.29B | 0.29B | 0.29B | 0.29B | 0.29B | 0.29B | 0.29B | 0.29B |
| Cash flow | ||||||||||
| Cash from operations | $1.9B | $2.1B | $2.3B | $2.4B | $1.9B | $2.1B | $1.8B | $2.4B | $2.8B | $3.0B |
| Capital expenditure | $757M | $869M | $779M | $731M | $489M | $643M | $713M | $775M | $995M | $1.0B |
| Free cash flow | $1.2B | $1.2B | $1.5B | $1.7B | $1.4B | $1.4B | $1.1B | $1.6B | $1.8B | $1.9B |
| Depreciation and amortization | $851M | $894M | $729M | $775M | $813M | $843M | $939M | $924M | $936M | $977M |
| Stock-based compensation | $85.7M | $90.5M | $88.0M | $84.0M | $82.1M | $89.5M | $87.8M | $95.1M | $135M | $137M |
| Acquisitions | $85.0M | $989M | $230M | $391M | $487M | $3.9B | $7.2M | $180M | $313M | $1.6B |
| Share buybacks | $740M | $600M | $562M | $354M | $146M | $107M | $518M | $13.7M | $987M | $784M |
| Dividends paid | $428M | $449M | $495M | $553M | $561M | $566M | $603M | $617M | $664M | $754M |
| Dividends and buybacks | $1.2B | $1.0B | $1.1B | $907M | $707M | $673M | $1.1B | $631M | $1.7B | $1.5B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $327M | $211M | $115M | $119M | $1.3B | $360M | $599M | $920M | $1.3B | $646M |
| Total debt | $6.7B | $7.3B | $7.0B | $6.4B | $6.7B | $8.8B | $8.6B | $8.2B | $7.6B | $8.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $4.3B | $4.6B | $4.7B | $4.8B | $5.1B | $4.7B | $5.5B | $5.6B | $6.0B | $6.0B |
| Current liabilities | $3.0B | $3.5B | $3.7B | $3.6B | $2.9B | $3.6B | $4.2B | $4.3B | $4.8B | $5.5B |
| Inventory | $1.3B | $1.4B | $1.5B | $1.1B | $1.3B | $1.5B | $1.8B | $1.5B | $1.5B | $1.5B |
| Property and equipment, net | $3.4B | $3.7B | $3.8B | $3.2B | $3.1B | $3.3B | $3.3B | $3.5B | $3.8B | $4.3B |
| Total assets | $18.3B | $20.0B | $20.1B | $20.9B | $18.1B | $21.2B | $21.5B | $21.8B | $22.4B | $24.7B |
| Total liabilities | $11.4B | $12.3B | $12.0B | $12.1B | $11.9B | $14.0B | $14.2B | $13.8B | $13.6B | $14.9B |
| Shareholders' equity | $6.9B | $7.6B | $8.0B | $8.7B | $6.2B | $7.2B | $7.2B | $8.0B | $8.8B | $9.8B |
| Margins | ||||||||||
| Gross margin | 42.7% | 41.7% | 43.8% | 43.9% | 41.4% | 40.2% | 37.8% | 40.2% | 43.5% | 44.5% |
| Operating margin | 14.2% | 14.1% | 14.1% | 14.7% | 11.8% | 12.6% | 11.0% | 13.0% | 17.8% | 17.0% |
| EBITDA margin | 20.7% | 20.6% | 20.1% | 20.9% | 18.7% | 19.2% | 17.6% | 19.0% | 23.8% | 23.1% |
| Net margin | 9.5% | 11.0% | 11.8% | 12.6% | β10.1% | 8.9% | 7.7% | 9.0% | 13.4% | 12.9% |
| FCF margin | 9.0% | 8.8% | 12.3% | 13.5% | 11.6% | 11.1% | 7.6% | 10.7% | 11.6% | 11.8% |
| Returns | ||||||||||
| Return on capital | 10.6% | 12.0% | 9.3% | 10.3% | 8.9% | 9.5% | 8.4% | 10.3% | 15.3% | 13.8% |
| Return on capital employed | 12.8% | 12.3% | 10.5% | 11.0% | 8.6% | 9.7% | 9.0% | 11.5% | 16.0% | 14.9% |
| Return on equity | 18.1% | 21.0% | 18.5% | 18.9% | β16.0% | 16.9% | 15.1% | 18.0% | 25.1% | 22.4% |
| Return on assets | 6.7% | 7.9% | 7.2% | 7.7% | β6.1% | 5.8% | 5.1% | 6.3% | 9.6% | 8.8% |
| Growth | ||||||||||
| Revenue growth | β2.9% | 5.2% | β11.7% | 2.8% | β6.1% | 8.0% | 11.4% | 8.0% | 2.8% | 2.2% |
| Net income growth | 22.5% | 21.8% | β5.2% | 9.4% | β175.2% | β | β3.4% | 25.7% | 53.9% | β1.7% |
| EPS growth | 24.7% | 23.7% | β4.7% | 9.2% | β177.9% | β | β2.6% | 25.7% | 53.9% | β1.2% |
| FCF growth | β3.7% | 3.4% | 22.6% | 12.7% | β18.8% | 3.5% | β24.2% | 52.2% | 11.1% | 4.7% |
| Share count change | β1.6% | β0.9% | β0.4% | β0.1% | β0.8% | β0.4% | β0.9% | β0.0% | 0.0% | β0.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.3x | 2.5x | 2.8x | 2.4x | 2.5x | 3.4x | 3.2x | 2.5x | 1.7x | 2.0x |
| Debt / equity | 1.0x | 1.0x | 0.9x | 0.7x | 1.1x | 1.2x | 1.2x | 1.0x | 0.9x | 0.8x |
| Interest coverage | 6.6x | 7.1x | 7.3x | 8.6x | 4.6x | 6.9x | 6.2x | 5.7x | 8.2x | 8.9x |
| Current ratio | 1.4x | 1.3x | 1.3x | 1.3x | 1.8x | 1.3x | 1.3x | 1.3x | 1.3x | 1.1x |
| Quick ratio | 1.0x | 0.9x | 0.9x | 1.0x | 1.3x | 0.9x | 0.9x | 1.0x | 1.0x | 0.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.8% | 6.3% | 6.4% | 5.8% | 4.2% | 5.1% | 5.0% | 5.1% | 6.3% | 6.5% |
| Stock comp / revenue | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.6% | 0.6% | 0.9% | 0.9% |
| Payouts / FCF | 98.7% | 85.8% | 70.5% | 53.7% | 51.6% | 47.4% | 104.2% | 38.6% | 90.7% | 80.7% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 6.0 | 6.0 | 9.0 | 4.0 | 6.0 | 5.0 | 8.0 | 7.0 | 5.0 |
| Altman Z'' | 3.0 | 3.0 | 3.1 | 3.3 | 3.3 | 2.8 | 2.8 | 3.1 | 3.6 | 3.2 |
| Accruals ratio | β3.8% | β3.0% | β4.2% | β4.1% | β15.6% | β4.7% | β3.3% | β4.8% | β3.2% | β3.7% |
Source: SEC EDGAR XBRL filings (CIK 0000031462). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.